TrialCancer2024

High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.

Luke J Peppone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.